Literature DB >> 1618912

Release of iron by human retinal pigment epithelial cells.

R C Hunt1, A A Davis.   

Abstract

Retinal pigment epithelial cells, which form one aspect of the blood-retinal barrier, take up iron in association with transferrin by a typical receptor-mediated mechanism (Hunt et al., 1989. J. Cell Sci. 92:655-666). This iron is dissociated from transferrin in a low pH environment and uptake is sensitive to agents that inhibit endosomal acidification. The dissociated iron enters the cytoplasm as a low molecular weight (less than 10 kD) component and subsequently binds to ferritin. No evidence for recycling of iron in association with transferrin was found. Nevertheless, much of the iron that is taken up is recycled to the extracellular medium, primarily from the low molecular weight pool. This release of iron is not sensitive to inhibitors of energy production or of vesicular acidification but is increased up to a maximum of about 40% of the total 55Fe incorporated when cells are incubated with serum or the medium is changed. When a short loading time for 55Fe from 55Fe-transferrin is used (i.e., when the low molecular weight pool is proportionately larger), a much larger fraction of the cell-associated radiolabel is released than when longer loading times are used. The data suggest that a releasable intracellular iron pool is in equilibrium with the externalized material. The released iron may be separated into a high and a low molecular weight component. The former is similar on polyacrylamide gel electrophoresis to ferritin although it cannot be immune precipitated by anti-ferritin antibodies. The low molecular weight 55Fe which is heterogeneous in nature can be bound by external apo-transferrin and may represent a form that can be taken up by cells beyond the blood-retinal barrier.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1618912     DOI: 10.1002/jcp.1041520114

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  14 in total

Review 1.  How does the macula protect itself from oxidative stress?

Authors:  James T Handa
Journal:  Mol Aspects Med       Date:  2012-04-05

Review 2.  Iron, the retina and the lens: a focused review.

Authors:  Sixto García-Castiñeiras
Journal:  Exp Eye Res       Date:  2010-03-15       Impact factor: 3.467

Review 3.  Iron metabolism in the eye: a review.

Authors:  M Goralska; J Ferrell; J Harned; M Lall; S Nagar; L N Fleisher; M C McGahan
Journal:  Exp Eye Res       Date:  2008-11-21       Impact factor: 3.467

4.  Cd-Cysteine Nanorods as a Fluorescence Sensor for Determination of Fe (III) in Real Samples.

Authors:  Ebrahim Ghiamati; Ramin Boroujerdi
Journal:  J Fluoresc       Date:  2015-10-30       Impact factor: 2.217

5.  Ferroxidase hephaestin's cell-autonomous role in the retinal pigment epithelium.

Authors:  Natalie Wolkow; Delu Song; Ying Song; Sally Chu; Majda Hadziahmetovic; Jennifer C Lee; Jared Iacovelli; Steven Grieco; Joshua L Dunaief
Journal:  Am J Pathol       Date:  2012-02-17       Impact factor: 4.307

6.  Alpha-synuclein modulates retinal iron homeostasis by facilitating the uptake of transferrin-bound iron: Implications for visual manifestations of Parkinson's disease.

Authors:  Shounak Baksi; Ajai K Tripathi; Neena Singh
Journal:  Free Radic Biol Med       Date:  2016-06-23       Impact factor: 7.376

Review 7.  Iron homeostasis and toxicity in retinal degeneration.

Authors:  Xining He; Paul Hahn; Jared Iacovelli; Robert Wong; Chih King; Robert Bhisitkul; Mina Massaro-Giordano; Joshua L Dunaief
Journal:  Prog Retin Eye Res       Date:  2007-08-11       Impact factor: 21.198

8.  N-tert-butyl hydroxylamine, a mitochondrial antioxidant, protects human retinal pigment epithelial cells from iron overload: relevance to macular degeneration.

Authors:  Ludmila A Voloboueva; David W Killilea; Hani Atamna; Bruce N Ames
Journal:  FASEB J       Date:  2007-07-26       Impact factor: 5.191

9.  Disruption of ceruloplasmin and hephaestin in mice causes retinal iron overload and retinal degeneration with features of age-related macular degeneration.

Authors:  Paul Hahn; Ying Qian; Tzvete Dentchev; Lin Chen; John Beard; Zena Leah Harris; Joshua L Dunaief
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-13       Impact factor: 11.205

10.  Pretreatment with pyridoxamine mitigates isolevuglandin-associated retinal effects in mice exposed to bright light.

Authors:  Casey D Charvet; Aicha Saadane; Meiyao Wang; Robert G Salomon; Henri Brunengraber; Illarion V Turko; Irina A Pikuleva
Journal:  J Biol Chem       Date:  2013-08-22       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.